Target intelligence / Profile preview

RNA, 5S ribosomal pseudogene 281 (RNA5SP281)

Target
RNA5SP281
Molecular classification
Other (Pseudogene), Non-coding RNA, Ribosomal RNA pseudogene
01

Overview

RNA, 5S ribosomal pseudogene 281 (abbreviated as RNA5SP281) is a predicted human pseudogene related to 5S ribosomal RNA[2]. Pseudogenes are DNA sequences resembling functional genes but are typically non-functional due to the accumulation of disabling mutations or lack of regulatory elements required for expression[5]. The 5S ribosomal RNA gene is normally a component of the ribosome, crucial for ribosome structure and translation in the cell[1][3][5]. Pseudogenes like RNA5SP281 are not transcribed into functional 5S rRNA and do not participate in ribosome biogenesis or function[5]. While some pseudogenes can exert regulatory effects (such as acting as competitive endogenous RNAs), there is no evidence that RNA5SP281 encodes any functional RNA or has any direct biological or pathological role[2][5]. Some pseudogenes, including other 5S ribosomal pseudogenes, have been broadly implicated as potential genetic markers for cancer sub-classification due to altered expression patterns in tumors, but RNA5SP281 has no established functional or disease role, nor is it a therapeutic target[4][6]. Justification for "is_incorrect": RNA5SP281 is not a receptor, enzyme, transporter, or therapeutic target but rather a pseudogene—a non-functional segment related to 5S rRNA[2][5]. Thus, treating it as a therapeutic "target" is conceptually incorrect. It is not druggable, is not implicated in recognized disease pathways, and has no validated biological activity.

Other names
RN5S281RNA, 5S ribosomal 281RNA5SP281
02

Biological functions

None (no known direct biological function; classified as a pseudogene)
03

Disease associations

Other (Pseudogene expression, including 5S ribosomal pseudogenes in general, can act as molecular markers in cancer subtype stratification due to altered or aberrant transcription[4][6]. However, no direct, specific disease association or functional role is documented for RNA5SP281.)
04

Biomarkers

None validated; pseudogenes in general (not specifically RNA5SP281) are under study as potential cancer biomarkers[4][6].

Beyond the preview

Go deeper on RNA, 5S ribosomal pseudogene 281 (RNA5SP281).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on RNA, 5S ribosomal pseudogene 281 (RNA5SP281).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call